Bucindolol: new hopes from reviewing past data.
Publication
, Journal Article
Fiuzat, M; O'Connor, CM
Published in: Drugs Today (Barc)
May 2011
β-Adrenoceptor antagonists or β-blockers are a cornerstone of therapy in chronic heart failure (CHF). Bucindolol hydrochloride is a fourth-generation β-blocker in development for the treatment of CHF. Two trials have been conducted to evaluate its use in CHF, and a third is under way to investigate bucindolol for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population. This review aims to summarize the history, pharmacology and clinical trials of bucindolol.
Duke Scholars
Published In
Drugs Today (Barc)
DOI
ISSN
1699-3993
Publication Date
May 2011
Volume
47
Issue
5
Start / End Page
347 / 351
Location
Spain
Related Subject Headings
- Propanolamines
- Pharmacology & Pharmacy
- Humans
- Heart Failure
- Clinical Trials as Topic
- Chronic Disease
- Adrenergic beta-Antagonists
- 3214 Pharmacology and pharmaceutical sciences
- 3211 Oncology and carcinogenesis
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fiuzat, M., & O’Connor, C. M. (2011). Bucindolol: new hopes from reviewing past data. Drugs Today (Barc), 47(5), 347–351. https://doi.org/10.1358/dot.2011.47.5.1579112
Fiuzat, M., and C. M. O’Connor. “Bucindolol: new hopes from reviewing past data.” Drugs Today (Barc) 47, no. 5 (May 2011): 347–51. https://doi.org/10.1358/dot.2011.47.5.1579112.
Fiuzat M, O’Connor CM. Bucindolol: new hopes from reviewing past data. Drugs Today (Barc). 2011 May;47(5):347–51.
Fiuzat, M., and C. M. O’Connor. “Bucindolol: new hopes from reviewing past data.” Drugs Today (Barc), vol. 47, no. 5, May 2011, pp. 347–51. Pubmed, doi:10.1358/dot.2011.47.5.1579112.
Fiuzat M, O’Connor CM. Bucindolol: new hopes from reviewing past data. Drugs Today (Barc). 2011 May;47(5):347–351.
Published In
Drugs Today (Barc)
DOI
ISSN
1699-3993
Publication Date
May 2011
Volume
47
Issue
5
Start / End Page
347 / 351
Location
Spain
Related Subject Headings
- Propanolamines
- Pharmacology & Pharmacy
- Humans
- Heart Failure
- Clinical Trials as Topic
- Chronic Disease
- Adrenergic beta-Antagonists
- 3214 Pharmacology and pharmaceutical sciences
- 3211 Oncology and carcinogenesis
- 1115 Pharmacology and Pharmaceutical Sciences